These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30608989)

  • 1. Role of genomic DNA methylation in detection of cytologic and histologic abnormalities in high risk HPV-infected women.
    Dankai W; Khunamornpong S; Siriaunkgul S; Soongkhaw A; Janpanao A; Utaipat U; Kitkumthorn N; Mutirangura A; Srisomboon J; Lekawanvijit S
    PLoS One; 2019; 14(1):e0210289. PubMed ID: 30608989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CADM1, MAL, and miR124 Promoter Methylation as Biomarkers of Transforming Cervical Intrapithelial Lesions.
    Del Pino M; Sierra A; Marimon L; Martí Delgado C; Rodriguez-Trujillo A; Barnadas E; Saco A; Torné A; Ordi J
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31067838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of
    Molano M; Machalek DA; Tan G; Garland S; Balgovind P; Haqshenas G; Munnull G; Phillips S; Badman SG; Bolnga J; Cornall AM; Gabuzzi J; Kombati Z; Brotherton J; Saville M; Hawkes D; Kaldor J; Toliman PJ; Vallely AJ; Murray GL
    BMJ Open; 2024 Jun; 14(6):e081282. PubMed ID: 38904134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical significance of FAM19A4 methylation in high-risk HPV-positive cervical samples for the detection of cervical (pre)cancer in Chinese women.
    Bu Q; Wang S; Ma J; Zhou X; Hu G; Deng H; Sun X; Hong X; Wu H; Zhang L; Luo X
    BMC Cancer; 2018 Nov; 18(1):1182. PubMed ID: 30486875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Follow-up of high-risk HPV positive women by combined cytology and bi-marker CADM1/MAL methylation analysis on cervical scrapes.
    Verhoef VM; van Kemenade FJ; Rozendaal L; Heideman DA; Bosgraaf RP; Hesselink AT; Melchers WJ; Massuger LF; Bekkers RL; Steenbergen RD; Berkhof J; Snijders PJ; Meijer CJ
    Gynecol Oncol; 2015 Apr; 137(1):55-9. PubMed ID: 25667975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of
    Holubekova V; Mersakova S; Grendar M; Snahnicanova Z; Kudela E; Kalman M; Lasabova Z; Danko J; Zubor P
    Genet Test Mol Biomarkers; 2020 May; 24(5):256-263. PubMed ID: 32311274
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined promoter methylation analysis of CADM1 and MAL: an objective triage tool for high-risk human papillomavirus DNA-positive women.
    Hesselink AT; Heideman DA; Steenbergen RD; Coupé VM; Overmeer RM; Rijkaart D; Berkhof J; Meijer CJ; Snijders PJ
    Clin Cancer Res; 2011 Apr; 17(8):2459-65. PubMed ID: 21389098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined CADM1 and MAL promoter methylation analysis to detect (pre-)malignant cervical lesions in high-risk HPV-positive women.
    Overmeer RM; Louwers JA; Meijer CJ; van Kemenade FJ; Hesselink AT; Daalmeijer NF; Wilting SM; Heideman DA; Verheijen RH; Zaal A; van Baal WM; Berkhof J; Snijders PJ; Steenbergen RD
    Int J Cancer; 2011 Nov; 129(9):2218-25. PubMed ID: 21190187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation as a triage marker for colposcopy referral in HPV-based cervical cancer screening: a systematic review and meta-analysis.
    Salta S; Lobo J; Magalhães B; Henrique R; Jerónimo C
    Clin Epigenetics; 2023 Aug; 15(1):125. PubMed ID: 37533074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of DNA methylation-based biomarkers in the cervical cancer screening program of northern Portugal: A feasibility study.
    Salta S; Maia-Moço L; Estevão-Pereira H; Sequeira JP; Vieira R; Bartosch C; Petronilho S; Monteiro P; Sousa A; Baldaque I; Rodrigues J; Sousa H; Tavares F; Henrique R; Jerónimo C
    Int J Cancer; 2021 Dec; 149(11):1916-1925. PubMed ID: 34460099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology.
    Shen-Gunther J; Wang CM; Poage GM; Lin CL; Perez L; Banks NA; Huang TH
    Clin Epigenetics; 2016; 8(1):96. PubMed ID: 27651839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease.
    Bierkens M; Hesselink AT; Meijer CJ; Heideman DA; Wisman GB; van der Zee AG; Snijders PJ; Steenbergen RD
    Int J Cancer; 2013 Sep; 133(6):1293-9. PubMed ID: 23456988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing the performance of FAM19A4 methylation analysis, cytology and HPV16/18 genotyping for the detection of cervical (pre)cancer in high-risk HPV-positive women of a gynecologic outpatient population (COMETH study).
    Luttmer R; De Strooper LM; Berkhof J; Snijders PJ; Dijkstra MG; Uijterwaal MH; Steenbergen RD; van Kemenade FJ; Rozendaal L; Helmerhorst TJ; Verheijen RH; Ter Harmsel WA; Van Baal WM; Graziosi PG; Quint WG; Heideman DA; Meijer CJ
    Int J Cancer; 2016 Feb; 138(4):992-1002. PubMed ID: 26317579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene methylation of CADM1 and MAL identified as a biomarker of high grade anal intraepithelial neoplasia.
    Phillips S; Cassells K; Garland SM; Machalek DA; Roberts JM; Templeton DJ; Jin F; Poynten IM; Hillman RJ; Grulich AE; Murray GL; Tabrizi SN; Molano M; Cornall AM;
    Sci Rep; 2022 Mar; 12(1):3565. PubMed ID: 35241698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined CADM1/MAL methylation and cytology testing for colposcopy triage of high-risk HPV-positive women.
    De Strooper LM; Hesselink AT; Berkhof J; Meijer CJ; Snijders PJ; Steenbergen RD; Heideman DA
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1933-7. PubMed ID: 24962840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytology and high risk HPV testing in cervical cancer screening program: Outcome of 3-year follow-up in an academic institute.
    Yang J; Nolte FS; Chajewski OS; Lindsey KG; Houser PM; Pellicier J; Wang Q; Ehsani L
    Diagn Cytopathol; 2018 Jan; 46(1):22-27. PubMed ID: 29048733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotyping for Human Papillomavirus (HPV) 16/18/52/58 Has a Higher Performance than HPV16/18 Genotyping in Triaging Women with Positive High-risk HPV Test in Northern Thailand.
    Khunamornpong S; Settakorn J; Sukpan K; Suprasert P; Srisomboon J; Intaraphet S; Siriaunkgul S
    PLoS One; 2016; 11(6):e0158184. PubMed ID: 27336913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylation marker analysis of self-sampled cervico-vaginal lavage specimens to triage high-risk HPV-positive women for colposcopy.
    Hesselink AT; Heideman DA; Steenbergen RD; Gök M; van Kemenade FJ; Wilting SM; Berkhof J; Meijer CJ; Snijders PJ
    Int J Cancer; 2014 Aug; 135(4):880-6. PubMed ID: 24474183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up.
    De Strooper LMA; Berkhof J; Steenbergen RDM; Lissenberg-Witte BI; Snijders PJF; Meijer CJLM; Heideman DAM
    Int J Cancer; 2018 Sep; 143(6):1541-1548. PubMed ID: 29663363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylation in human papillomavirus-infected cervical cells is elevated in high-grade squamous intraepithelial lesions and cancer.
    Kim MK; Lee IH; Lee KH; Lee YK; So KA; Hong SR; Hwang CS; Kee MK; Rhee JE; Kang C; Hur SY; Park JS; Kim TJ
    J Gynecol Oncol; 2016 Mar; 27(2):e14. PubMed ID: 26768780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.